The association of MMP-2 (matrix metalloproteinase 2, 72-kD collagenas
e IV) with invasive and metastatic capacity of tumor cells has implica
ted a potential role in the prognosis for cancer patients. However, no
larger study has been done to prove this hypothesis. The present stud
y was therefore designed to investigate the prognostic impact of MMP-2
in a prospective series of 203 gastric cancer patients. MMP-2 express
ion was measured immunohistochemically and scored semiquantitatively (
score 0-3) in carcinoma cells, and results were correlated with clinic
opathological tumor parameters and parameters of the urokinase-type pl
asminogen activator (uPA) system. Survival analyses were done using th
e Kaplan-Meier method (log-rank statistics) and multivariate Cox analy
sis. Significant correlations were found for MMP-2 and Lauren's classi
fication, M stage and proteases/inhibitors of the uPA system in the pr
imary tumor. Kaplan-Meier analysis revealed an association of increasi
ng MMP-2 expression with worse prognosis. This was especially seen in
patients with a parallel high expression of uPA receptor. However, dif
ferences in survival probabilities between low and high MMP-2 levels w
ere not significant. In a separate analysis of diffuse-type cancers, M
MP-2 was significantly associated with disease-free (p = 0.0056) and o
verall survival (p = 0.0426). Multivariately, MMP-2 was not an indepen
dent parameter. Our results demonstrate that there is an association o
f immunohistochemical detection of MMP-2 with prognosis of cancer pati
ents. For diffuse gastric cancers, it is a significant prognostic para
meter, however, not of independent impact. The study further suggests
that consideration of interrelated tumor-associated proteases like uPA
receptor in combination with MMP-2 may improve its prognostic power.